Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Mol Genet Metab. 2015 Dec 2;117(2):144–149. doi: 10.1016/j.ymgme.2015.11.013

Table 1.

Clinical data for mucopolysaccharidosis IV A patients.

ID Height (cm) Height Z-score Weight (kg) Age (yrs) Sex ERT Genotype Ambulatory status
1 88.9 –2.2 12.7 3.3 M N n/a F
2 97 –2.2 16.2 4.9 F N n/a F
3 99.1 –3.5 15.9 6.1 F Y p.G301C/G301C F
4 86.4 –8.7 13.2 9.1 M Y n/a P/N
5 106.7 –8.7 37.6 15.9 F N n/a P/N
6 91.44 –8.7 28.6 16.3 F N P.ivs8 + 1G > c/ivs8 + 1G > c P/N
7 114.3 –7.7 35.5 18 F N p.S287L/L352P P/N
8 116.8 –8.1a 33.2 18.9 M Y n/a P/N
9 113.8 –8.5a 34.7 21.0 M Y n/a F
10 96.5 –10.1a 25.4 21.1 F N n/a P/N
11 118 –8.0a 34.5 22.4 M N p.G42E/P125L F
12 126 –5.7a 34.5 23.0 F N n/a P/N
13 129.5 –5.2a 36.4 25.6 F N p.S287L/L352P F
14 91.4 –10.8a 22.7 30.6 F N p.M41K/M41K P/N
15 91.4 –10.8a 25.5 34.2 F N n/a F
16 122 –6.3a 34.4 36.5 F N n/a F
17 106.7 –8.6a 36.4 40.8 F N n/a P/N
18 96.5 –10.1a 24 38.4 F N n/a F

ERT = enzyme replacement therapy; F = full-time ambulator; P/N = partial or non-ambulator.

a

Based on age 20 years.